The European Union has given CE Mark of approval to Intrinsic Therapeutics, a Woburn, Massachusetts firm, to market its Barricaid® ARD device. The prosthesis is designed to serve as a partial disc replacement to reconstruct the fibrous ring surrounding the edge of intervertebral discs.
To learn more about the device, head to this product page for Barricaid® that also features an animation demonstrating the implantation of the device.
Press release: Intrinsic Therapeutics Announces CE Mark for Barricaid Anular Prosthesis …